Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 4,000.00
+275.00 (7.38%)
Nov 2, 2026, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 93.03 billion as of October 30, 2026. It is the 27,887th most valuable company in the world and the 1,319th biggest in South Korea. Its market cap has decreased by 56.94% in one year.
Market Cap
93.03B
Enterprise Value
54.98B
Revenue
n/a
Global Rank
Country Rank
#1,319 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 93.03B, a decrease of -41.94%. That is a compound annual growth rate of -8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 93.03B | -59.96% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 170.37B |
| NeoImmuneTech | 155.82B |
| GC Cell | 151.77B |
| Anterogen.Co.,Ltd. | 133.68B |
| MedPacto | 104.54B |
| Genexine | 98.24B |
| iNtRON Biotechnology | 86.19B |
| Amicogen | 64.54B |